Management of a Parkinson’s disease patient with severe COVID-19 pneumonia
Open Access
- 1 January 2020
- journal article
- case report
- Published by SAGE Publications in Therapeutic Advances in Chronic Disease
- Vol. 11
Abstract
Elderly populations with underlying chronic diseases are more vulnerable to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and have higher mortality. Parkinson’s disease (PD) is a neurodegenerative disease that occurs more often in elderly people. Currently, little is known about whether patients with PD are more susceptible to novel coronavirus disease 2019 (COVID-19) and whether the treatment of PD would affect the management of COVID-19 or vice versa. Here, we report a case of a PD patient with severe COVID-19 pneumonia in Wuhan, China. After diagnosis of COVID-19, this PD patient had worsening of motor symptoms, complicated with acute hypoxemic respiratory failure, urinary tract infection, and acute encephalopathy. In addition to treatment for COVID-19 and urinary tract infection, we adjusted anti-PD medicine by stepwise increasing of dose, resulting in better control of her mobility symptoms and non-motor symptoms.Keywords
This publication has 16 references indexed in Scilit:
- Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, ChinaJAMA Neurology, 2020
- COVID-19: An Early Review of Its Global Impact and Considerations for Parkinson’s Disease Patient CareJournal of Movement Disorders, 2020
- Parkinson's Disease and COVID‐19: Perceptions and Implications in Patients and CaregiversMovement Disorders, 2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Impact of the COVID‐19 Pandemic on Parkinson's Disease and Movement DisordersMovement Disorders Clinical Practice, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host–Virus Interaction, and Proposed Neurotropic MechanismsACS Chemical Neuroscience, 2020
- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, ChinaIntensive Care Medicine, 2020
- Age-related neurodegenerative disease research needs aging modelsFrontiers in Aging Neuroscience, 2015
- Non-motor symptoms of Parkinson's disease: diagnosis and managementThe Lancet Neurology, 2006